Insight

Medical devices 2030:

Making a power play to avoid the commodity trap

The days of simply manufacturing a device, and selling it to healthcare providers via distributors, have long vanished.  Value is the new byword for success, prevention the preferred clinical outcome, and intelligence the new competitive advantage. This paper examines the pathway to success in 2030 for medical device organizations.

Medical devices 2030

Making a power play to avoid the commodity trap

Related content

Our practice

KPMG can help healthcare and life sciences organizations solve their toughest business challenges.